Valo biotech

cited “current market conditions, particularly in the biotechnology area,” as the reason for calling off the deal, announced in June, which would have Each map is a playground to showcase your creative thinking. WHEN: Decem­ber 6, 2021 . Previous Next. Scius Communications. and Our Journey. The pact with Valo follows Website: Valo Therapeutics. “TARA’s proprietary human cardiac disease They are all coming back. I. HELSINKI, Finland, Oct. katja@sciuscommunications. 5 million upfront, $17. Valo is a new type of technology company, uniting human and machine intelligence aiming to accelerate the creation of life-changing cures. Ahmad received an MS in Global Health Policy Management from the London School of Hygiene and Tropical Medicine, U. Sep 3, 2004 · Alexandre Valo Laboratory for Environmental Biotechnology, National Institute for Agronomic Research (INRA), Avenue des Etangs, 11100 Narbonne, France Search for more papers by this author Morgan Stanley, Putting the Tech in Biotech: Exploring the World of Tech-Enabled Drug Development. Khus or Vetiveria Zizanioides, commonly known as Valo, is a versatile and highly beneficial herb that has been used for centuries in traditional medicine and various applications. 2B with to develop oncology Sep 25, 2023 · Valo is also eligible to receive milestone payments for up to 11 programmes, totalling up to $2. BOSTON, Sept. Panacea Biotec is an Innovation driven company doing Research and Development, Manufacturing, Sales, Distribution and Marketing of Nutrition, Vaccines & Pharmaceuticals. Dr Zocca is a biotech entrepreneur, founder and co-founder of several biotech spin-outs, and an expert in the development of immunotherapies for cancer. He joins IO Biotech from Novartis, where he most recently served as Senior Vice President, US Head of Clinical Development & Medical Affairs, for the Novartis Oncology business unit. VALO BioMedia is making an important contribution to the health of humans and animals. Valo Health Biotechnology Research Lexington, MA Chemo Pharmaceutical Manufacturing Madrid, Madrid Ceva Santé Animale Pharmaceutical Manufacturing Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API. health tech company Valo Health struck a deal to use AI to find treatments for cardiometabolic diseases. Apr 29, 2021 · Valo Health, LLC (Valo) is a technology company that is using human-centric data and artificial intelligence (AI) computation to transform the drug discovery and development process. As a Sep 20, 2022 · Share this article. Email: matthew. Join Us. 7 billion, plus research and development funding and potential royalty payments, Novo said. 69 Following. 5 million in installments and $10 million in equity David Berry to Participate in NewYorkBio and New York Stock Exchange Emerging Biotech Company Showcase. 20, 2022 /PRNewswire/ -- Valo Health, Inc ("Valo"), the technology company focused on transforming the drug discovery and development process using human-centric Valo Therapeutics Announces First Patient Dosed with PeptiCRAd-1 - Innovative Immuno-oncology valotx. David Berry discussed his precedent-setting ambition behind founding Valo. A biotech­nol­o Jul 27, 2021 · Valo Health LLC, a drugmaker valued at about $2. Matthew Vaughan. Nov 13, 2023 · About Valo Health Valo Health, Inc is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics. Mai-Britt Zocca, PhD is Founder and Chief Executive Officer (CEO) of IO Biotech. Tour’s USA leg starts on April 1, 2023 from Philadelphia’s Theatre of the Living Arts and ends at Irving Plaza, New York on BOSTON, MA (Decem­ber 1, 2021) — Valo Health, LLC (“Valo”), the tech­nol­o­gy com­pa­ny using human-cen­tric data and arti­fi­cial intel­li­gence (AI) pow­ered com­pu­ta­tion to trans­form the drug dis­cov­ery and devel­op­ment process, announced today that its CEO and founder, David Berry, will par­tic­i­pate in this year’s NewYork­Bio and New York Stock Jun 8, 2020 · Contacts. Aug 30, 2023 · The Danish pharmaceutical giant is satisfying that hunger by acquiring a startup with a novel approach to weight loss, marking its second acquisition agreement this month. BOSTON, April 5, 2022 /PRNewswire/ -- Valo Health, LLC ("Valo"), announced today the acquisition of TARA Biosystems, Inc. Our unique approach to immunotherapy, based on oncolytic viruses and viral vectors combined Jun 10, 2021 · Valo launched in 2019 out of Flagship Pioneering, the Cambridge-based investor and incubator that spun out the breakout biotech Moderna. Valorant Tracker is Riot compliant. The team has collected thousands of samples from 40 percent of Earth’s biomes Apr 18, 2024 · Charles River Laboratories has launched a new project to cut down on animal testing in drug discovery. As part of the deal, Valo will receive a $168. The candidate was created in partnership with Exscientia, a company Dec 3, 2021 · EVENT: NewYork­Bio & NYSE ’s Emerg­ing Biotech Com­pa­ny Showcase . 7bn if a milestone of 11 programmes is reached, as well as R&D funding and potential royalty payments. Valo Therapeutics. Valo has pioneered a new approach to target discovery and drug development - one that is based on high-quality, high-density data with scalable computational capabilities, all built on a single integrated architecture. Dec 4, 2023 · AstraZeneca is the latest drugmaker to open its wallet, agreeing to pay Absci up to $247 million to collaborate on the design of an anti-cancer antibody. 528 Followers. Valo Health, an AI-powered drug discovery company is opening its office at 90 Nassau Street, the company announced Oct 10, 2023 · HELSINKI, Finland, Oct. com Joined September 2020. (September 24, 2020) – Flagship Pioneering today announced the launch of Valo Health, LLC (Valo), a drug discovery technology company setting out to transform how oncology, neurodegenerative, and cardiovascular disease drugs are created, developed, and approved. vaughan@valotx. Als führender Produzent von Eiern und verwandten biologischen Medien, die sowohl zur Herstellung von Human- und Tierimpfstoffen als auch für die pharmazeutische Forschung genutzt werden, verstehen wir uns als integraler Bestandteil der weltweiten Jan 30, 2023 · Berry also has aspirations of bringing about wide adoption with Valo, which announced a hefty Series B in 2021. , and Graeme Bell among the investors, the biotech hailed the extra funding in a press release just days ago. TARA’s “heart-on-a-chip” system creates a small, working simulacrum of the beating organ to help May 27, 2021 · In April of this year, the German biotechnology company Evotec announced a phase 1 clinical trial on a new anticancer molecule. This root possesses a rich array of properties, including antimicrobial, anti-inflammatory, and antioxidant capabilities. Full Event: 12: 00 PM — 6: 00 PM EST Jan 19, 2022 · Charles River Labs, an early-stage contract research organization, is diving deeper into artificial intelligence by inking a multiyear partnership with Valo Health. Published on Jan. Learn about VALORANT and its stylish cast. Speaking about the new role, Pesonen says, “I’m thrilled to become Valo’s CSO after 5 years heading R&D at Valo, pursuing my passion to develop immunotherapy platforms. In 2022, the company is planning an IPO. Founded and initially capitalized by Flagship Pioneering in 2019 Sep 25, 2023 · Valo Health, Inc is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics. H. The latest buyout target We’re delighted to announce Exothera will be developing a large-scale manufacturing process for the clinical development of VALO-D102, our proprietary, innovative oncolytic adenovirus which Exciting day here at Valo as we announce our acquisition of Courier Therapeutics! "We are enthusiastic about Courier's proprietary cell-targeting technology… BCBN Feed: Valo Health Completes Enrollment of OPL-0401 Phase 2 Study for the Treatment of Diabetic Retinopathy https://lnkd. In this role he is accountable for strategy and activities to support the progression of Valo’s research platform and drug discovery pipeline. 8 billion that has agreed to go public by merging with a blank-check company, has acquired a biotechnology startup and diversified its pipeline. We consider ourselves to be an integral part of global health care as a leading producer of eggs and related biological media, which are used for the production of human and veterinary vaccines as well as for pharmaceutical research. The patents cover the pharmaceutical composition and Oct 12, 2023 · Helsinki, Finland, 10 Oct 2023 – Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapies for cancer, announces it is the first biotech company in Europe to install and use the Bruker Corporation’s new timsTOF Ultra mass spectrometer and liquid chromatography platform, which provides transformative speed and sensitivity for antigen identification in connection with Aug 26, 2021 · PRINCETON, NJ — A biotech company is all set to open a new office in Princeton. Finland biotech’s focus on sustainability Jan 30, 2023 · What Prompted This Entrepreneur To Launch Biotech Company Valo. This appointment Jun 8, 2020 · /PRNewswire/ -- Valo Therapeutics Limited (Valo Tx), an immuno-oncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines, Sep 3, 2004 · Alexandre Valo Laboratory for Environmental Biotechnology, National Institute for Agronomic Research (INRA), Avenue des Etangs, 11100 Narbonne, France Search for more papers by this author Oct 20, 2023 · Valo Health: Using AI for Drug Discovery Valo Health is a pioneering biotech startup that is leveraging the power of artificial intelligence (AI) in the field of drug discovery. Alexandre Valo Laboratory for Environmental Biotechnology, National Institute for Agronomic Research (INRA), Avenue des Etangs, 11100 Narbonne, France Search for more papers by this author Feb 14, 2023 · Valo Therapeutics Oy (Helsinki) is an immunotherapy company that is developing antigen-coated oncolytic viruses and vaccine vectors as therapeutic vaccines against cancer and infectious disease Oct 10, 2023 · Top-of-the-Line Molecular Analytics Instrument with Transformative Sensitivity will enable Rapid Identification of Tumor Antigens. We expect our platform will be a powerful system to deliver advanced individualised or ‘patient-specific’ cancer treatments, in indications including metastatic Oxford, UK and Helsinki, Finland, 3rd August 2020: Valo Therapeutics Limited (Valo Tx), an immuno-oncology company developing targeted therapeutics using tumor antigen-coated oncolytic viruses, today announced it had appointed industry veteran Paul G Higham as Chief Executive Officer (CEO), to lead the company through a Series A round and take its PeptiCRAd platform into first-in-human cancer About Us. Our unique approach, based on the selective use of oncolytic and non-replicating vectors with disease-specific peptides, delivers a highly specific Combined Company to Spearhead Transformation of Cardiovascular Disease Drug Discovery and Development. The startup begins life with close to $100 million, Forma Therapeutics’ hit discovery capabilities and ambitions to Valo Health to Participate in UBS Biotechnology Virtual Private Company Symposium September 5, 2022 Valo Health To Participate in Citi's 17th Annual BioPharma Conference August 31, 2022 Valo Announces First Patient Dosed in the OPL-0401 Phase 2 study of an oral ROCK1/2 inhibitor for the Treatment of Non-Proliferative Diabetic Retinopathy Reinventing Immunotherapy in Oncology and Infectious Disease. January 19, 2022 • Forbes. She has participated in founding and co-founding of several biotech spinouts. Apr 6, 2022 · Valo, formerly known as Integral Health, received a big financial boost last year to chase these goals. in/eABbvnap with Novo Nordisk. “I’m focused on continuing to build and scale Valo to become the standard drug discovery and development platform for the pharmaceutical industry,” he said. , Ph. Written by Stephen Ostrowski. Jun 11, 2024 · In 2023, Valo Therapeutics began dosing patients in their phase 1 trial of PeptiCRAd-1 to evaluate the safety, immune activity, and tumor response of this innovative therapy both alone and in combination with pembrolizumab. Replies. Valo Health. Science & Technology Boston, MA valohealth. The Valo Health team recently co-published this paper https://lnkd. The company’s Opal Computational Platform™, a fully integrated, computational, endtoend drug development platform, offers a Nov 16, 2021 · Több tízmilliárdos céget építeni önmagában sem könnyű feladat, de megőrizni a kezdeti vállalati kultúrát még nehezebb. Novo Nordisk is also licensing three preclinical drug discovery May 3, 2022 · Valo Health, Inc (“Valo”), the tech­nol­o­gy com­pa­ny focused on trans­form­ing the drug dis­cov­ery and devel­op­ment process using human-cen­tric data and arti­fi­cial intel­li­­gence-pow­ered com­pute, announced that its founder and CEO, David Berry, will par­tic­i­pate in the Piper San­dler Spring Biotech Sym­po­sium, on May 3 rd in Cam­bridge, MA. 5 million Valo Health Is Partnering With Charles River Laboratories To Accelerate Preclinical Drug Discovery. Development Portfolio and Program Management. Riot Games presents VALORANT: a 5v5 character-based tactical FPS where precise gunplay meets unique agent abilities. ("TARA"), a New York City-based cardiovascular disease biotechnology company, creating the first of its kind vertically integrated cardiovascular drug discovery and Jul 27, 2021 · BOSTON, July 27, 2021 / PRNewswire/ — Valo Health, LLC (“Valo”), the tech­nol­o­gy com­pa­ny built to trans­form the drug dis­cov­ery and devel­op­ment process using human-cen­tric data and arti­fi­cial intel­li­gence-dri­ven com­pute, today announced its acqui­si­tion of Couri­er Ther­a­peu­tics. Logica™ is a customized turnkey drug discovery solution from target to preclinical development that is transforming drug discovery. With their Opal computational platform, Valo Health aims to accelerate the drug development process by using AI algorithms to analyze vast amounts of data and identify VALO BioMedia leistet einen wichtigen Beitrag für die Gesundheit von Menschen und Tieren. Business Area (s): Cancer Therapeutics. As part of the multi Valo is a technology company built to transform the drug discovery and development process using human-centric data and AI-powered computation. This combination is a highly immunogenic and rapidly adaptable tumor vaccination platform. Immunotherapy. Be part of Valo. Mar 9, 2021 · Valo, formerly known as Integral Health, launched after acquiring Forma Therapeutics’ hit discovery capabilities for $2. We calculate your performance to make sure you are on top of the competition. Now, Valo and Khosla Ventures have Valo Therapeutics (ValoTx) is a developer of novel immunotherapies in cancer and infectious disease. In November 2019, Valo acquired San Sep 2, 2020 · Valo is a technology company transforming the drug discovery and development process using its Opal Platform, human-centric data, and AI-powered compute. ValoTx is developing novel immunotherapies for cancer that are projected to transform treatment and prevention for millions of patients. Zocca has more than 18 years of experience in the biotech field especially focusing on translational/clinical immune oncology with development of immunotherapies for cancer diseases. A BioTechUSA két ügyvezetőjével, Lévai Bálinttal és Lévai Balázzsal beszélgettünk arról, hogyan lehet csapatot építeni és nagyvállalattá gyarapodni úgy, hogy a cég által képviselt értékek mutassanak túl a kliséken és a patikamérlegen Sep 14, 2023 · Launched in 2022 by Charles River and biotech research firm Valo Health, Logica combines CRL’s preclinical insights with Valo’s AI-powered drug discovery system, Opal. Val­o’s Founder and CEO, David Berry will present at Mor­gan Stan­ley’s, Putting the Tech in Biotech: Explor­ing the World of Tech-Enabled Drug Devel­op­ment event 2: 00 PM — 2: 45 PM ET on Tues­day, June 28, 2022 in New York, NY Apr 26, 2022 · Valo Health nabs TARA Biosystems and its beating heart-on-a-chip. Careers. Sep 23, 2020 · The company was founded around 18 months ago and in July 2019 raised a series A round of nearly $100 million from Flagship Pioneering and PSP Investments. Prior to joining Valo, Michael was the initial Chief Science Officer at TARA Biosystems, a New York City-based biotech company developing human stem cell derived tissues models to support Jan 5, 2022 · In 2021, Valo raised €11M that will fund the final preparations for a phase I clinical trial of its lead cancer treatment. Katja Stout. Dr. COVID-19. Valo is a new type of technology company, uniting human and machine intelligence aiming to accelerate the creation of life Valo is a new type of technology company, uniting human and machine intelligence aiming to accelerate the creation of life-changing cures. Creating Innovative ways for enhanced customer experience each time every time. com 128 5 Comments Oct 6, 2021 · Berry has founded more than 20 agriculture, biotech and technology companies during his 16-year tenure at Flagship Pioneering. Valorant Tracker is an in-game real-time tracking solution for your Valorant stats. Valo could receive up to $2. To help boost its drug discovery and development work in cardiovascular disease, Valo Health is acquiring TARA Biosystems, makers of a 3D heart tissue modeling platform. . M’s former frontman Ville Valo has launched his new single Loveletting recently, released under the VV banner, with an announcement of his 2023 headline tour of Europe and North America. Valo aims to fully integrate human Jun 8, 2020 · Dr Michael Stein, CEO of Valo Tx, commented, "We're delighted to have Mai-Britt join our Board, with her wealth of expertise as a biotech entrepreneur and immunotherapy developer. He is currently CEO of Flagship-founded firm Valo Health. Valo will receive $60 million up front, and could get Aug 16, 2022 · The firm raised $451M in an initial public offering on the Nasdaq and accompanying private placement in October 2021, with more than $470M raised overall, and has many partnerships with big pharma and the biotech industry, namely Evotec, Bristol-Myers Squibb, Bayer and Sanofi, which it signed a deal worth up to $5. Compare Valo Health to its competitors by revenue, employee growth and other metrics at Craft. The company is listed in a briefing that discusses the growing importance of technologies in immuno-oncology, suggesting that it is part of an innovative and expanding field. Purpose-built for team strategies, spectacular plays, and clutch moments. The Alternative Methods Advancement Project, or AMAP, will involve adding animal model AI-Powered Drug Discovery. Additionally, Valo received regulatory approval to expand the trial to sarcoma. Charles River and Valo’s combined offering increases certainty of small molecule drug discovery through delivery of advanceable leads and candidates, tying costs to value generation TARA Biosystems, a biotech startup that’s built a mechanism to generate human tissues outside of the body for drug development testing for cardiovascular therapeutics, has been acquired by Valo Health, a drug discovery and development platform that leverages AI-powered computation and data. Description: VALO TX is developing novel cancer immunotherapies that are based on an oncolytic virus non-covalently combined with tumor-specific peptides. WHAT: David Berry will join lead­ers from Cowen Inc and TMRW Life Sci­ence in a pan­el dis­cus­sion on the future of the biotech­nol­o­gy market. Valo is fully integrating human-centric data across the entire drug development lifecycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs Sep 25, 2023 · Novo Nordisk and privately-held U. Valo Therapeutics (ValoTx) is a spin-out company from the IVTLab at the University of Helsinki, Finland. After raising $190 million in venture capital funding last January, the company topped up Sep 25, 2023 · Valo will receive an upfront payment and a potential near-term milestone payment, totalling 60 million US dollars, and is eligible to receive milestone payments for up to 11 programmes, totalling Mar 27, 2020 · To boost the ‘vaccine’ effect of these viruses, Valo modifies them to carry tumor cell fragments that the immune system can recognize. We are always looking for talented people to join our dedicated team that is applying their combined power to innovate drug discovery and development in pursuit of better health outcomes for patients everywhere. Read More. 10, 2023 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapies for cancer, announces it is the first biotech company in Feb 16, 2023 · According to Charles River and Valo, the AI software can produce an advanceable lead series 90% of the time, which will in turn translate into legitimate development candidates 58% of the time BOSTON, MA (August 31, 2022) — Valo Health, Inc (“Valo”), the tech­nol­o­gy com­pa­ny focused on trans­form­ing the drug dis­cov­ery and devel­op­ment process using human-cen­tric data and arti­fi­cial intel­li­gence, announced that David Berry, founder & CEO of Valo will present at the UBS Biotech­nol­o­gy Vir­tu­al Pri­vate Com­pa­ny Sym­po­sium on Sep­tem Nov 15, 2021 · Valo and Khosla Ventures Acquisition Co. European biotech beyond 2022. The European biotech industry has been rapidly growing in recent years, rivaling the biotechnology sector of North America and Asia. D. of London, a Master of Clinical Oncology Sep 26, 2023 · Valo will receive an upfront payment and a potential near-term milestone payment of $60m, the companies said in a statement on Monday (27th Sept). S. Current Job Openings. 26, 2023. 30, 2023. ValoTx has assembled a uniquely talented team of oncolytic virus and immunotherapy experts, who together with the founding scientist have the necessary expertise to take its patented technology through clinical development and make it Flagship Pioneering has lifted the lid on its latest biotech: Valo Health. in/gBEbtNCp BOSTON, March 4, 2024… . December 3, 2021 • Valo Health. Several other companies are also developing oncolytic virus cancer vaccines, such as the French firm Transgene, the Swiss biotech Nouscom, and the US companies Turnstone Biologics and Profectus Biosciences. View App. Valo Health's main competitors include ENTEROME, Q32 Bio, Structure Therapeutics and Koneksa Health. Vaccines. Berry, Valo’s CEO, who co-founded more BOSTON, MA (August 31, 2022) — Valo Health, Inc (“Valo”), the technology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence, announced that David Berry, founder & CEO of Valo will present at the UBS Biotechnology Virtual Private Company Symposium on September 22, 2022 from 11:30 AM EST to 11:55 AM EST. +44 (0) 7789435990. Valo engineers advances that lead to high-impact breakthroughs by applying emerging techniques in computing to human data, reducing the cost and time of drug development while increasing confidence the medicines will work. Absci has contributed to an uptick in Sep 23, 2020 · Flagship Pioneering founded Valo in early 2019 to change how drugs are developed. , founder and Chief Exec­u­tive Offi­cer of Valo will par­tic­i­pate in a pan­el dis­cus­sion dur Basecamp Research’s technology helps move us away from petrochemicals as the basis of our products, and toward more sustainable solutions using biology as the basis. The company has already increased the number of proteins known to science by 50 percent. Make the play others will imitate for years to come. Sep 23, 2020 · BOSTON, Mass. Kudos to Julia Eve Napolitano, Steve Sorota… Shared by David Berry Sep 14, 2023 · In 2022, Charles River and Valo Health launched Logica, Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and Boston, MA (June 2, 2022) Valo Health, Inc (“Valo”), the tech­nol­o­gy com­pa­ny focused on trans­form­ing the drug dis­cov­ery and devel­op­ment process using human-cen­tric data and arti­fi­cial intel­li­gence, announced a proof of con­cept for using its pre­clin­i­cal asset, OPL-0101, to tar­get CD 8 + T cells, in the cur­rent issue and fea­tured on the cov­er of Sep 25, 2023 · Boston-based health-tech company Valo Health has entered into an agreement with Den­mark-based drugmaker Novo Nordisk to develop new treatments for diseases that lead to heart attack, stroke and Valo Therapeutics Ltd 3,384 followers 3h Report this post We’re proud to announce we have received regulatory approval to expand our Phase I trial into two subtypes of sarcoma: synovial and Jan 16, 2024 · Valo Health, Inc ("Valo"), a technology company focused on utilizing large scale data and artificial intelligence ("AI") driven computation to discover and develop therapeutics, today announced Get the Free In-Game App. Valo aims to fully integrate human-centric data across the entire drug development life cycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs Valo Health, LLC (Valo), the tech­nol­o­gy com­pa­ny that is using human-cen­tric data, machine learn­ing com­pu­ta­tion, and life sci­ence exper­tise to trans­form and accel­er­ate the drug dis­cov­ery and devel­op­ment process, today announced that David Berry, Ph. 10, 2023 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapies for cancer, announces it is the first biotech company in Europe to install and use the Bruker Corporation’s new timsTOF Ultra Jan 26, 2023 · What Prompted This Entrepreneur To Launch Biotech Company Valo. “With only 1,500 approved drugs for 13,000 diseases, [rewriting the drug discovery process] is the transformation that patients need. Associate Director, Portfolio & Program Management Lexington, Massachusetts, United Valo Therapeutics may be growing as it is mentioned alongside other companies in the context of the biotechnology industry, indicating its relevance in the sector. com. Be part of a culture that emphasizes trust and diversity, where people are generous with their ideas, support their colleagues, and feel free to voice their opinions. Nov 17, 2021 · With Valo executives David Berry, M. ”. We’re focused on bringing together the brilliant minds of Data Platform experts, Software Engineers, Early Discovery Chemistry aficionados, Preclinical Helsinki, Finland, 16th Feb, 2023 - Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapies for cancer and infectious diseases, announces it has been granted European patents EP3768305 and EP3768830, issued by the European Patent Office (EPO) on 7 February 2023. tl lx pf xl nx cy qh kl bi vu